Mark J Walker

24PUBLICATIONS
134CO-AUTHORS
NanomedicineBiogeography and phylogeographyHealth and ecological risk assessmentMedical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 02, 2026
Current progress in developing mRNA-lipid nanoparticle vaccines against human bacterial pathogens.

|Apr 23, 2026
Emergence of distinct Streptococcus pyogenes emm1 and emm12 lineages in China.

|Feb 10, 2026
NeuO-mediated O-acetylation of uropathogenic <i>Escherichia coli</i> K1 capsule enhances resistance to phage and neutrophil killing.

Lachlan L Walker, Nguyen Thi Khanh Nhu, Zheng Jie Lian

|Feb 09, 2026
Acquisition of toxin-encoding lysogenic bacteriophage elements enhances the virulence of pandemic <i>Streptococcus pyogenes</i> M1<sub>UK</sub>.

Juan Manuel Díaz, Jasmine E J Wells, Amanda C Marple

|Jul 03, 2025
Group A Streptococcus interacts with glycosaminoglycans via M proteins to modulate bacterial adherence in vitro.

Tahnee B-D McEwan, David M P De Oliveira, Emily K Stares

|Jul 01, 2025
An mRNA vaccine encoding five conserved Group A Streptococcus antigens.

Nichaela Harbison-Price, Ismail Sebina, Rhiannon A Bolton

Pageof 4

Frequent Collaborators

12 joint publications

Mark R Davies

10 joint publications

Stephan Brouwer

9 joint publications

David M P De Oliveira

6 joint publications

Amanda J Cork